How Selegiline ((-)-Deprenyl) Slows Brain Aging:
Saved in:
Bibliographic Details
Main Author: Knoll, J. (Author)
Format: Electronic eBook
Language:English
Published: [Place of publication not identified] Bentham Science Publishers 2012
Subjects:
Online Access:FAW01
FAW02
Item Description:Includes bibliographical references and indexes
Cover; Title; EUL; Contents; Foreword; Abbreviations; Keywords; Introduction; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Summary and Conclusion; Epilogue; References; Appendix; Author Index; Subject Index
This e-book is a reference on Selegiline (( - )-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. (( - )-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra
Physical Description:xvi, 142 pages
ISBN:1608054705
9781608054701
9781608055944

There is no print copy available.

Interlibrary loan Place Request Caution: Not in THWS collection!